There has been a global decline in childhood measles vaccination rates since the COVID-19 pandemic, according to a study published online Oct. 21 in Nature Medi ...

Patient and consumer representatives on U.S. Food and Drug Administration advisory committees frequently have ties to pharmaceutical industry-funded groups.

Patients with geographic atrophy prefer treatments that preserve reading ability and distance vision despite potential risks of inflammation.

Researchers assessed preoperative lesion area as a predictor of final defect size in periocular basosquamous carcinoma cases.

The FDA has expanded the approval of Ryzumvi (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults based on phase 3 VEGA trial data.

The FDA has approved Brytly (apraclonidine ophthalmic solution 0.125%) as an over-the-counter treatment for minor eye redness ...